FMP
Second Sight Medical Products, Inc.
EYES
NASDAQ
Inactive Equity
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
4.14 USD
-0.22000027 (-5.31%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. Matthew Pfeffer
sector
Healthcare
industry
Medical - Devices
website
https://www.secondsight.comexchange
NASDAQ
Description
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction. Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The compa...
CIK
0001266806
ISIN
US81362J2096
CUSIP
81362J209
Address
12744 San Fernando Rd Bldg 3
Phone
18188335000
Country
US
Employee
15
IPO Date
Nov 19, 2014
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
EYES Financial Summary
CIK
0001266806
Exchange
NASDAQ
Industry
Medical - Devices
Sector
Healthcare
CUSIP
81362J209
ISIN
US81362J2096
Country
US
Price
4.14
Beta
2.56
Volume Avg.
0
Market Cap
210.05M
Shares
-
52-Week
-
DCF
7.52
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://www.secondsight.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest EYES News
It looks like there's no news available.
